Get started
Author

Susan Y. Smith

Observed names: Smith, Susan Y, Susan Smith, Susan Y Smith, Susan Yvonne Smith
OpenAlex ID: A5110855133
Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
2010 · Michael S Ominsky, Fay Vlasseros, et al. · Journal of Bone and Mineral Research · 416
PDF
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
2010 · Michael S Ominsky, Chaoyang Li, et al. · Journal of Bone and Mineral Research · 265
Defining a Noncarcinogenic Dose of Recombinant Human Parathyroid Hormone 1–84 in a 2-Year Study in Fischer 344 Rats
2006 · Jacquelin Jolette, Clynn E. Wilker, et al. · Toxicologic Pathology · 142
Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys
2011 · Patricia J Masarachia, Brenda L Pennypacker, et al. · Journal of Bone and Mineral Research · 115
Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits
2010 · Brenda L Pennypacker, Le T Duong, et al. · Journal of Bone and Mineral Research · 109
Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys
2016 · Michael S Ominsky, Steven K Boyd, et al. · Journal of Bone and Mineral Research · 104
PDF
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
2011 · Paul J. Kostenuik, Susan Y. Smith, et al. · Bone · 100
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
2011 · Michael S. Ominsky, Brian Stouch, et al. · Bone · 98
Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1–34)
2017 · Jacquelin Jolette, Bassem Attalla, et al. · Regulatory Toxicology and Pharmacology · 96
PDF
Intermittent Ibandronate Preserves Bone Quality and Bone Strength in the Lumbar Spine After 16 Months of Treatment in the Ovariectomized Cynomolgus Monkey
2004 · Ralph Müller, Mary Hannan, et al. · Journal of Bone and Mineral Research · 90
PDF
Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study
2016 · Luc Chouinard, Melanie Felx, et al. · Regulatory Toxicology and Pharmacology · 84
PDF
One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption
2016 · Aurore Varela, Luc Chouinard, et al. · Journal of Bone and Mineral Research · 76
PDF
Prevention of Bone Loss in Ovariectomized Rats by Combined Treatment With Risedronate and 1α,25-Dihydroxyvitamin D3
2002 · Reinhold G. Erben, Lis Mosekilde, et al. · Journal of Bone and Mineral Research · 66
Treatment of Skeletally Mature Ovariectomized Rhesus Monkeys With PTH(1-84) for 16 Months Increases Bone Formation and Density and Improves Trabecular Architecture and Biomechanical Properties at the Lumbar Spine
2006 · John Fox, Michael A Miller, et al. · Journal of Bone and Mineral Research · 56
One year of abaloparatide, a selective peptide activator of the PTH1 receptor, increased bone mass and strength in ovariectomized rats
2016 · Aurore Varela, Luc Chouinard, et al. · Bone · 53
PDF
Effects of Denosumab, Alendronate, or Denosumab Following Alendronate on Bone Turnover, Calcium Homeostasis, Bone Mass and Bone Strength in Ovariectomized Cynomolgus Monkeys
2014 · Paul J Kostenuik, Susan Y Smith, et al. · Journal of Bone and Mineral Research · 41
PDF
Skeletal effects of bazedoxifene paired with conjugated estrogens in ovariectomized rats
2011 · Barry S. Komm, Fay Vlasseros, et al. · Bone · 36
Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone
2014 · Mitsuru Saito, Marc D. Grynpas, et al. · Bone · 34
PDF
A Toxicity Profile of Osteoprotegerin in the Cynomolgus Monkey
2003 · Brenda Smith, Mary Ellen Cosenza, et al. · International Journal of Toxicology · 32
Bone Toxicology
2017 · Samadfam, Rana, Varela, Aurore, et al. · Molecular and integrative toxicology · 25
Early elevation in circulating levels of C‐telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen‐induced arthritis
2006 · Svetlana Oestergaard, Luc Chouinard, et al. · Arthritis & Rheumatism · 23
The Effect of Rosiglitazone on Bone Mass and Fragility Is Reversible and Can Be Attenuated With Alendronate
2013 · Sanjay Kumar, Sandra J Hoffman, et al. · Journal of Bone and Mineral Research · 22
Long-Term Treatment with Eldecalcitol (1α, 25-Dihydroxy-2β- (3-hydroxypropyloxy) Vitamin D3) Suppresses Bone Turnover and Leads to Prevention of Bone Loss and Bone Fragility in Ovariectomized Rats
2014 · Satoshi Takeda, Susan Y. Smith, et al. · Calcified Tissue International · 19
Assessment of a Nonsteroidal Aromatase Inhibitor, Letrozole, in Juvenile Rats
2013 · Louise Pouliot, Marilynn Schneider, et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 18
Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
2013 · Susan Y. Smith, Nancy Doyle, et al. · Bone · 18
PDF
Works count: 46
Citation count: 2,301
H-index: 22
I10-index: 35
Year
Topic
Type